Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes
Journal
Diabetes and Metabolism
Journal Volume
44
Journal Issue
1
Pages
77-79
Date Issued
2018
Author(s)
SDGs
Other Subjects
pioglitazone; 2,4 thiazolidinedione derivative; antidiabetic agent; pioglitazone; age; cancer incidence; cancer patient; cancer risk; chronic obstructive lung disease; diabetic patient; disease duration; drug exposure; hazard ratio; human; ICD-9; Letter; lung cancer; major clinical study; non insulin dependent diabetes mellitus; priority journal; propensity score; sex; Taiwanese; tobacco dependence; case control study; complication; lung tumor; non insulin dependent diabetes mellitus; Taiwan; Case-Control Studies; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Lung Neoplasms; Taiwan; Thiazolidinediones
Publisher
Elsevier Masson SAS
Type
letter